Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase
Observational
Started
2026-07-01
Last updated
2026-06-09
Condition(s) studied
Colon CancerRectal Cancer
Study summary
The goal of this observational study is to learn about the spatial distribution and significance of metastatic lymph nodes in colorectal cancer patients. The main question it aims to answer is:
* What is the spatial distribution pattern of metastatic lymph nodes in patients with colorectal cancer?
* Can the spatial distribution pattern of metastatic lymph nodes in patients with colorectal cancer guide clinical practice? Participants should undergo regular follow-up examinations for at least 5 years after the surgery.
Eligibility
Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria:
* Aged between 18 and 80 years
* Pathologically confirmed adenocarcinoma of the colon or rectum
* Underwent radical resection for colorectal cancer with a D3 lymphadenectomy and lymph nodes were submitted for pathological examination according to standardized station-based and distance-based protocol
* No distant metastasis or distant metastasis within 6 months after surgery
* No history of other malignant tumors or severe systemic diseases
* No immune diseases or inflammatory bowel diseases
* Non-emergency surgery
* With complete clinicopathological and follow-up data
Exclusion Criteria:
* Pathologically confirmed benign tumors or non-adenocarcinoma malignancies
* Underwent local excision or palliative resection
* Regional lymph nodes were not dissected or submitted for pathological examination according to the unified station-based or distance-based protocol
* With distant metastasis or distant metastasis within 6 months after surgery
* Dual or multiple primary colorectal cancers or concurrent other malignant tumors
* Had a previous diagnosis of immune diseases or inflammatory bowel disease such as ulcerative colitis or Crohn's disease
* Underwent emergency surgery
* Had incomplete clinicopathological or follow-up data
Primary outcome measure(s)
The spatial distribution of metastatic lymph nodes — From enrollment to 14 days after surgery (at the completion of postoperative pathological examination)
Trial sites (1)
Facility
City
Region
Status
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences
Beijing
China
More Cancer Institute and Hospital, Chinese Academy of Medical Sciences trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.